DIPLOMAT PHARMACY INC's ticker is DPLO and the CUSIP is 25456K101. A total of 130 filers reported holding DIPLOMAT PHARMACY INC in Q3 2015. The put-call ratio across all filers is 0.74 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $433,000 | -46.7% | 71,140 | +17.9% | 0.02% | -51.9% |
| Q4 2018 | $812,000 | -61.1% | 60,321 | -42.0% | 0.05% | -43.5% |
| Q4 2017 | $2,087,000 | +447.8% | 104,020 | +464.4% | 0.09% | +384.2% |
| Q3 2017 | $381,000 | -52.7% | 18,430 | -66.1% | 0.02% | -55.8% |
| Q2 2017 | $805,000 | -80.9% | 54,441 | -79.4% | 0.04% | -77.9% |
| Q1 2017 | $4,219,000 | +81.6% | 264,521 | +43.4% | 0.20% | +40.3% |
| Q4 2016 | $2,323,000 | +280.8% | 184,400 | +745.9% | 0.14% | -29.4% |
| Q3 2016 | $610,000 | -19.0% | 21,800 | +29.4% | 0.20% | +688.0% |
| Q2 2015 | $753,000 | -44.0% | 16,849 | -56.7% | 0.02% | -45.7% |
| Q1 2015 | $1,345,000 | +140.2% | 38,923 | +90.3% | 0.05% | +119.0% |
| Q4 2014 | $560,000 | – | 20,454 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 7,036,670 | $42,853,000 | 1.54% |
| ARMISTICE CAPITAL, LLC | 3,200,000 | $19,488,000 | 1.23% |
| STEPHENS INC /AR/ | 6,600,015 | $40,194,000 | 0.91% |
| S&T BANK/PA | 610,367 | $3,718,000 | 0.82% |
| Rhenman & Partners Asset Management AB | 1,203,405 | $7,329,000 | 0.81% |
| Matarin Capital Management, LLC | 701,445 | $4,272,000 | 0.30% |
| Investors Research Corp | 89,727 | $546,000 | 0.28% |
| Advisory Services Network, LLC | 598,802 | $3,647,000 | 0.22% |
| FCG ADVISORS, LLC | 34,000 | $207,000 | 0.06% |
| EVERENCE CAPITAL MANAGEMENT INC | 52,730 | $321,000 | 0.05% |